Insights

Innovative Therapeutics AnTolRx specializes in developing novel nanoformulation therapies aimed at inducing antigen-specific immune tolerance, addressing the unmet clinical need for targeted autoimmune disease treatments with fewer side effects than standard broad-spectrum therapies.

Recent Funding Activity In 2016, AnTolRx secured a $4 million investment led by Pfizer, demonstrating strong interest and validation from a major pharmaceutical player, which can open avenues for collaboration or early engagement in future funding rounds.

Specialized Market Focus The company's focus on autoimmune diseases, such as diabetes, positions it well within the growing market for precision immune therapies, appealing to healthcare providers seeking targeted treatment options.

Partnership Opportunities With a small, agile team and a proprietary approach, AnTolRx presents opportunities for strategic partnerships with larger biotech or pharma companies interested in expanding their portfolio into immune tolerance therapies.

Technology and Innovation Utilizing advanced nanoformulation techniques and proprietary drug development methods, AnTolRx is positioned at the forefront of biotech innovation, which can be attractive for clients seeking cutting-edge immune modulation solutions.

Similar companies to AnTolRx, Inc.

AnTolRx, Inc. Tech Stack

AnTolRx, Inc. uses 8 technology products and services including MySQL, jQuery, PHP, and more. Explore AnTolRx, Inc.'s tech stack below.

  • MySQL
    Database
  • jQuery
    Javascript Libraries
  • PHP
    Programming Languages
  • Google Tag Manager
    Tag Management
  • Bootstrap
    UI Frameworks
  • ExactMetrics
    Web Platform Extensions
  • Apache HTTP Server
    Web Servers
  • easy pie chart
    Web Tools And Plugins

AnTolRx, Inc.'s Email Address Formats

AnTolRx, Inc. uses at least 1 format(s):
AnTolRx, Inc. Email FormatsExamplePercentage
First.Last@antolrx.comJohn.Doe@antolrx.com
100%

Frequently Asked Questions

Where is AnTolRx, Inc.'s headquarters located?

Minus sign iconPlus sign icon
AnTolRx, Inc.'s main headquarters is located at 1 Kendall Square Building 1400 West Cambridge, Massachusetts 02139 US. The company has employees across 1 continents, including North America.

What is AnTolRx, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact AnTolRx, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is AnTolRx, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
AnTolRx, Inc.'s official website is antolrx.com and has social profiles on LinkedIn.

What is AnTolRx, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
AnTolRx, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does AnTolRx, Inc. have currently?

Minus sign iconPlus sign icon
As of March 2020, AnTolRx, Inc. has approximately 10 employees across 1 continents, including North America. Key team members include Co Founder, Director: F. J. Q.Senior Scientist: J. K.. Explore AnTolRx, Inc.'s employee directory with LeadIQ.

What industry does AnTolRx, Inc. belong to?

Minus sign iconPlus sign icon
AnTolRx, Inc. operates in the Biotechnology Research industry.

What technology does AnTolRx, Inc. use?

Minus sign iconPlus sign icon
AnTolRx, Inc.'s tech stack includes MySQLjQueryPHPGoogle Tag ManagerBootstrapExactMetricsApache HTTP Servereasy pie chart.

What is AnTolRx, Inc.'s email format?

Minus sign iconPlus sign icon
AnTolRx, Inc.'s email format typically follows the pattern of First.Last@antolrx.com. Find more AnTolRx, Inc. email formats with LeadIQ.

When was AnTolRx, Inc. founded?

Minus sign iconPlus sign icon
AnTolRx, Inc. was founded in 2016.
AnTolRx, Inc. logo

AnTolRx, Inc.

Biotechnology ResearchMassachusetts, United States2-10 Employees

AnTolRx, Inc. operates in the biotechnology research sector with a focus on autoimmune diseases. The company develops nanoformulation-based therapies aimed at inducing antigen-specific immune tolerance, seeking to provide targeted immune regulation that avoids the broad immunosuppression associated with conventional treatments. By focusing on selective targeting of pathogenic immune cells, AnTolRx aims to promote an anti-inflammatory phenotype and address unmet clinical needs in immune-related conditions. The organization is based in Cambridge, Massachusetts, and operates as a small team within the biotech ecosystem, pursuing advances in immune tolerance for diseases such as diabetes. A recent development noted in industry coverage involves the company’s activity within its research and development efforts, reflecting ongoing progress in its therapeutic approach.

Section iconCompany Overview

Headquarters
1 Kendall Square Building 1400 West Cambridge, Massachusetts 02139 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
2-10

Section iconFunding & Financials

  • $1M

    AnTolRx, Inc.'s revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    AnTolRx, Inc.'s revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.